Invitrogen Launches Solutions To Simplify DNA And RNA Workflows On Next-Generation Sequencing Systems
Invitrogen, part of Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced the introduction of two reagent solutions to simplify genomic and transcriptome analysis on next-generation, high-throughput genomic analysis platforms. Both solutions provide basic and clinical researchers with an innovative workflow that greatly reduces the time, cost, and experimental variability associated with next-generation sequencing library preparation.
More: continued here